FDA Approves Fall 2026 COVID Shots, Keeps Narrow Use
FDA approved updated, XFG-adapted 2026–2027 formula COVID-19 vaccines from Pfizer-BioNTech, Moderna, and Novavax on 27–28 August, each cleared by a strain-change supplement rather than a new licensing review. All three keep the same restricted indication FDA adopted a year ago: adults 65 and older, plus younger people with a qualifying high-risk condition — not the general population.